Catalyst Founder and President, Nancy Myers, will be moderating a panel on Thursday September 24th, 2020 at the (virtual) ASGCT Policy Summit. The panel will be on “Overcoming Regulatory Challenges in Gene Therapy Development.”

The panelists and their presentation topics are:

  • Anne-Virginie Eggimann, Senior Vice-President, Regulatory Science, bluebird bio
    “Regulatory considerations to improve gene therapy development throughout life cycle”
  • Ying Huang, Ph.D., Pharmacologist, Pharmacology/Toxicology Branch, FDA
    “Selecting appropriate animal models for clinical success”
  • Becky Schweighardt, Ph.D., Senior Director, Immunogenicity Assessment, BioMarin
    “Addressing immunogenicity in clinical trials”

For more information and to register, click HERE.